Kathy Fraser’s Post

View profile for Kathy Fraser, graphic

Editor In Chief at Adis, Springer Nature

Alexa B. Kimball, and colleagues review the current research on targeted therapies for hidradenitis suppurativa, including FDA-approved biologics and therapies in phase III and II trials. #hidradenitisSuppurativa #biologics #JAKinhibitors https://lnkd.in/g-SNJNhY

Hidradenitis Suppurativa: New Targets and Emerging Treatments - American Journal of Clinical Dermatology

Hidradenitis Suppurativa: New Targets and Emerging Treatments - American Journal of Clinical Dermatology

link.springer.com

To view or add a comment, sign in

Explore topics